Status | Study |
Withdrawn |
Study Name: Clofarabine for Langerhans in Pedi Condition: Langerhans Cell Histiocytosis Date: 2013-02-19 Interventions: Drug: Clofarabine |
Completed |
Study Name: Evaluation of Outcome of Adult Pulmonary Langerhans Cell Histiocytosis Based on Lung HRCT and Lung Function Condition: Pulmonary Langerhans Cell Histiocytosis Date: 2012-07-25 |
Active, not recruiting |
Study Name: Evaluation of Efficacy and Tolerance of Cladribine in Symptomatic Pulmonary Langerhans Cell Histiocytosis Condition: Langerhans Cell Histiocytosis of Lung Date: 2011-10-14 Interventions: Drug: Cladribine Subcutaneous injections, 0,1 mg/kg/day for 5 days, one course per month for 4 months |
Recruiting |
Study Name: A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell Histiocytosis Condition: Langerhans Cell Histiocytosis Date: 2011-07-12 Interventions: Drug: GSK2110183 Drug will be administered as 125 mg capsules once daily. |
Completed |
Study Name: Prospective Evaluation of Adult Pulmonary Langerhans Cell Histiocytosis Condition: Adult Pulmonary Langerhans Cell Histiocytosis Date: 2010-10-12 Interventions: Behavioral: Tabacco discontinuation Tabacco discontinuation |
Terminated |
Study Name: Reduced Intensity Hematopoietic Cell Transplantation for Patients With Resistant Langerhans Cell Histiocytosis Condition: Histiocytosis, Langerhans-cell Date: 2008-02-19 Interventions: Biological: alemtuzumab Admini |
Completed |
Study Name: Study of Sequential Administration of Oral 6-Thioguanine After Methotrexate in Patients With LCH Condition: Langerhans Cell Histiocytosis Date: 2007-12-26 Interventions: Drug: Methotrexate MTX 30mg/m2 |
Completed |
Study Name: H-9926-LCH III: Treatment Protocol of the Third International Study for Langerhans Cell Histiocytosis Condition: Leukemia Date: 2007-06-14 Interventions: Drug: Prednisone, Vinblastin, 6-mercaptopuroine |
Completed |
Study Name: Cardiovascular Risk Factors and LCH in Adults Condition: Histiocytosis, Langerhans-Cell Date: 2007-06-06 |
Completed |
Study Name: Combination Chemotherapy in Treating Young Patients With Langerhans Cell Histiocytosis Condition: Childhood Langerhans Cell Histiocytosis Date: 2006-01-12 Interventions: Drug: leucovorin calcium Drug: methotrexat |